ALEXION PHARMACEUTICALS, INC. Insider Trading for January 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ALEXION PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ALEXION PHARMACEUTICALS, INC. for January 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 13 2017 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Director | Option Exercise | S | 22.90 | 100 | 2,290 | 76,838 | |
| Jan 13 2017 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Director | Sell | S | 144.99 | 100 | 14,499 | 403,619 | 403.7 K to 403.6 K (-0.02 %) |
| Jan 13 2017 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Director | Buy | M | 22.90 | 100 | 2,290 | 403,719 | 403.6 K to 403.7 K (+0.02 %) |
| Jan 09 2017 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Option Exercise | M | 96.35 | 3,425 | 329,999 | 0 | |
| Jan 09 2017 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Option Exercise | M | 85.75 | 3,237 | 277,573 | 0 | |
| Jan 09 2017 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Option Exercise | M | 49.43 | 5,572 | 275,424 | 0 | |
| Jan 09 2017 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Option Exercise | M | 26.64 | 7,932 | 211,308 | 0 | |
| Jan 09 2017 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 141.22 | 22 | 3,107 | 3,880 | 3.9 K to 3.9 K (-0.56 %) |
| Jan 09 2017 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 140.59 | 117 | 16,449 | 3,902 | 4 K to 3.9 K (-2.91 %) |
| Jan 09 2017 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 139.49 | 435 | 60,678 | 4,019 | 4.5 K to 4 K (-9.77 %) |
| Jan 09 2017 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 138.60 | 421 | 58,351 | 4,454 | 4.9 K to 4.5 K (-8.64 %) |
| Jan 09 2017 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 137.56 | 599 | 82,398 | 4,875 | 5.5 K to 4.9 K (-10.94 %) |
| Jan 09 2017 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 135.69 | 31 | 4,206 | 5,474 | 5.5 K to 5.5 K (-0.56 %) |
| Jan 09 2017 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 133.95 | 15 | 2,009 | 5,505 | 5.5 K to 5.5 K (-0.27 %) |
| Jan 09 2017 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 133.65 | 853 | 114,003 | 5,520 | 6.4 K to 5.5 K (-13.38 %) |
| Jan 09 2017 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 141.23 | 278 | 39,262 | 6,373 | 6.7 K to 6.4 K (-4.18 %) |
| Jan 09 2017 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 140.59 | 1,433 | 201,465 | 6,651 | 8.1 K to 6.7 K (-17.73 %) |
| Jan 09 2017 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 139.49 | 5,350 | 746,272 | 8,084 | 13.4 K to 8.1 K (-39.82 %) |
| Jan 09 2017 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 138.60 | 5,176 | 717,394 | 13,434 | 18.6 K to 13.4 K (-27.81 %) |
| Jan 09 2017 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 137.56 | 7,375 | 1,014,505 | 18,610 | 26 K to 18.6 K (-28.38 %) |
| Jan 09 2017 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 135.70 | 369 | 50,073 | 25,985 | 26.4 K to 26 K (-1.40 %) |
| Jan 09 2017 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 133.95 | 185 | 24,781 | 26,354 | 26.5 K to 26.4 K (-0.70 %) |
| Jan 09 2017 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Buy | M | 96.35 | 3,425 | 329,999 | 26,539 | 23.1 K to 26.5 K (+14.82 %) |
| Jan 09 2017 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Buy | M | 85.75 | 3,237 | 277,573 | 23,114 | 19.9 K to 23.1 K (+16.29 %) |
| Jan 09 2017 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Buy | M | 49.43 | 5,572 | 275,424 | 19,877 | 14.3 K to 19.9 K (+38.95 %) |
| Jan 09 2017 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Buy | M | 26.64 | 7,932 | 211,308 | 14,305 | 6.4 K to 14.3 K (+124.46 %) |
| Jan 09 2017 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Director | Option Exercise | M | 22.90 | 4,853 | 111,134 | 76,938 | |
| Jan 09 2017 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Director | Option Exercise | M | 22.90 | 34,210 | 783,409 | 81,791 | |
| Jan 09 2017 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Director | Sell | S | 144.90 | 334 | 48,397 | 403,285 | 403.6 K to 403.3 K (-0.08 %) |
| Jan 09 2017 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Director | Sell | S | 144.93 | 4,853 | 703,345 | 403,619 | 408.5 K to 403.6 K (-1.19 %) |
| Jan 09 2017 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Director | Buy | M | 22.90 | 4,853 | 111,134 | 408,472 | 403.6 K to 408.5 K (+1.20 %) |
| Jan 09 2017 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Director | Sell | S | 139.90 | 334 | 46,727 | 403,619 | 404 K to 403.6 K (-0.08 %) |
| Jan 09 2017 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Director | Sell | S | 134.90 | 334 | 45,057 | 403,953 | 404.3 K to 404 K (-0.08 %) |
| Jan 09 2017 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Director | Sell | S | 139.98 | 17,105 | 2,394,358 | 404,287 | 421.4 K to 404.3 K (-4.06 %) |
| Jan 09 2017 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Director | Sell | S | 135.07 | 17,105 | 2,310,372 | 421,392 | 438.5 K to 421.4 K (-3.90 %) |
| Jan 09 2017 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Director | Buy | M | 22.90 | 34,210 | 783,409 | 438,497 | 404.3 K to 438.5 K (+8.46 %) |